Dear Scientific Committee for the 14th International mRNA Health Conference,
Please find all important deadlines and information needed for speaker invitation, planning the agenda and your participation at the conference here on this page.
We are looking forward to planning the next great conference with you!
Important deadlines and notes:
Abstract submission deadline: July 6, 2026
Abstract review deadline: July 27, 2026
Deadline for program: August 23, 2026
Please note: Sponsored talks (approx. 12×15 minutes and 6×5 minutes) and oral presentations will need to be included in the program. We will add sponsored talks below under the bullet point “sponsored talk topics”, as soon as we receive bookings with talking slots.
Speaker Suggestions for 2026
Please add your speaker suggestions as well as comments regarding suggestions from others by clicking the button below:
Sponsored talk topics
We will add topic/talk titles from the industry sponsored talks here as soon as we can so that you can insert them into the program accordingly.
| Silver package – 5 minutes: Arcalis | Talk Title: Speaker: |
| Silver package – 5 minutes: Eclipse BioInnovations | Talk Title: Lab-in-the-Loop: Closing the Design-Build-Test Gap in mRNA Development Speaker: Wayne Doyle |
| Silver package – 5 minutes: Primerose Bio | Talk Title: Choosing the Right Enzyme for RNA Manufacturing and Therapeutics Speaker: Patrik Engström |
| Silver package – 5 minutes: Sartorius Stedim North America | Talk Title: Speaker: |
Silver package – 5 minutes: | Talk Title: Speaker: |
| Silver package – 5 minutes: | Talk Title: Speaker: |
| Gold package – 15 minutes: Acuitas Therapeutics | Talk Title: Speaker: |
| Gold package – 15 minutes: Aldevron | Talk Title: Speaker: |
| Gold package – 15 minutes: Cytiva | Talk Title: Speaker: |
| Gold package – 15 minutes: EMD Millipore | Talk Title: Speaker: |
| Gold package – 15 minutes: FUJIFILM | Talk Title: Speaker: |
| Gold package – 15 minutes: Genevant Sciences | Talk Title: Innovative biodegradable lipids enable potent and safe delivery of nucleic acid therapeutics Speaker: Ed Yaworski |
Gold package – 15 minutes: | Talk Title: Speaker: |
| Gold package – 15 minutes: Polymun Scientific Immunbiologische Forschung GmbH | Talk Title: Speaker: |
| Gold package – 15 minutes: Roche CustomBiotech | Talk Title: Speaker: |
Gold package – 15 minutes: | Talk Title: Speaker: |
| Gold package – 15 minutes: | Talk Title: Speaker: |
Gold package – 15 minutes: | Talk Title: Speaker: |
Hotel booking and travel reimbursement
Please let us know your arrival and departure dates as soon as possible, so that we can book you into the conference hotel accordingly. Please send them via mail to n.eder@interplan.de.
After the conference, you can hand in your travel costs (flights in economy class) by using the travel reimbursement sheet you can find by clicking on the button below. All reimbursements will be made after the meeting by bank transfer.
Please note that in order to be able to reimburse your flight tickets and taxi payment, we require the boarding pass as well as the invoice/receipt stating the fare.
Suggested verbiage for speaker invitations
On behalf of the organizing committee, I am writing to invite you to speak at the 14th International mRNA Health Conference (https://www.mrna-conference.com/) to be held in Boston (USA) on Nov 17 – 19, 2026.
The International mRNA Health Conference is a yearly non-profit event collaboratively organized by Moderna, CureVac and BioNTech. It brings together academic and industry thought leaders in the mRNA design and delivery space to explore the rapidly evolving science, business and regulatory landscape of mRNA medicines. Over the last eleven years, this conference has become the premier destination for industry and academic professionals to network with colleagues, learn about the latest advances in mRNA technology, and to attend scientific presentations given by the most esteemed experts in the field. Notably, it is the only annual conference dedicated solely to mRNA-based medicines.
Building on the success of our hybrid meetings in the past three years, the conference will continue this format and have onsite as well as online attendees.
We think that conference attendees will be very interested to hear about your recent work on XXX.
If you accept our invitation, we are happy to waive your registration fee and cover all reasonable travel expenses (accommodation at the conference hotel and (economy) coach airfare or train tickets).
We sincerely hope that you will join us. We look forward to hearing from you at your earliest convenience.
Invited speakers from previous years
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| Hiroshi Abe Hayat Baehr-Mahmud James Byrne Pieter Cullis (Keynote) Lee Hyukjin Ana Jaklenec Anastasia Khvorova Kristin Koutmou Lena Kranz Robert Langer (Keynote) David Lockhart Julius Lucks Rachel Niederer Steve Pascolo Dan Peer Joseph Daniel Puglisi Bali Pulendran Elizabeth Rosado Balmayor Roy Bioyita Joel Rurik Robert Shattock Giovanni Traverso Wensheng Wei Hani Zaher | Vinod Balachandran Sumana Chandramouli Jeffrey Chao Phil Felgner (Keynote) Gaurav Sahay Magnus Hoffmann Kyle Holen Katalin Karikó (Keynote) Huang Liang Zoltán Kis Florian Leuschner Dal-Hee Min Janine Mühe Andre Nel Hamideh Parhiz Dan Peer Jamile Ramos da Silva Steve Roffler Qiaobing Xu | Hiroshi Abe Dan Anderson Elena Atochina-Vassermann Tim Beissert Sven Even Borgos Ling-Ling Chen Jeff Coller Yizhou Dong Ali Ellebedy Andy Ferguson Erol Fikrig Francis Impens Moritz Jansson Christian Kastrup Peter Marks (Keynote) Hai-Quan Mao Craig Martin Michael Mitchell Serena Omo-Lamai Yusuke Sato Elias Sayour Viviana Simon Xiao Wang Drew Weissmann (Keynote) John Wherry Anders Wittrup | Dan Barouch |
Program grid suggestion
Please find a suggestion for creating the agenda by clicking on the button below:
Sponsors 2026
We will add confirmed sponsors for 2026 here gradually.
| Gold | Silver | Bronze | Basic |
|---|---|---|---|
|
|
|
Sponsors 2025
| Gold | Silver | Bronze | Basic |
|---|---|---|---|
Acuitas Therapeutics, Inc. | ARCALIS, Inc. | Anemocyte Srl | Immagina Biotechnology Srl |